Study Links Higher Vitamin B2 and B6 Intake to Reduced Odds of Advanced CKM Syndrome
A recent analysis involving 14,576 U.S. adults has found that higher dietary intakes of vitamins B2 (riboflavin) and B6 (pyridoxine) are associated with significantly lower odds of advanced cardiovascular-kidney-metabolic (CKM) syndrome. Specifically, participants with the highest intake of vitamin B2 exhibited a 27% reduction in odds of developing advanced CKM syndrome compared to those with the lowest intake. Similarly, the highest intake of vitamin B6 was linked to a 26% decrease in odds of the syndrome, according to the study published in Frontiers in Nutrition.
CKM syndrome is a framework that highlights the interconnectedness of conditions such as heart disease, kidney disease, diabetes, and obesity. The researchers utilized data from the National Health and Nutrition Examination Survey collected between 2011 and 2020, and they observed a similar pattern in a separate cohort of 323 adults from China.
The study focused on six B vitamins, including B1, B2, B6, B12, niacin, and folate, and defined advanced CKM syndrome as stages 3 and 4, indicating a very high risk of cardiovascular disease or established cardiovascular disease. Participants provided information through two 24-hour dietary recalls, allowing researchers to estimate their intake of each B vitamin.
Adjustments were made for various factors, including age, income, smoking, alcohol use, physical activity, and overall diet quality. B vitamins are water-soluble nutrients that the body does not store, necessitating daily consumption to meet the body's requirements. The researchers also examined whether the same patterns were evident in the Chinese cohort, confirming similar associations.
When analyzing all six B vitamins collectively, B2 and B6 demonstrated the strongest correlation with advanced CKM syndrome. Niacin showed a smaller association, while B1 and folate were not consistently linked to the syndrome once adjustments were made for confounding factors.
The findings align with previous research indicating that B vitamins play a role in inflammation and oxidative stress. A study from Tufts University involving Puerto Rican elders found that vitamin B6 deficiency correlated with increased inflammation and chronic inflammatory conditions. Vitamins B6, B9, and B12 are known to assist in breaking down homocysteine, an amino acid associated with cardiovascular disease and decreased immune response.
Both B2 and B6 serve as essential cofactors for various enzymes, including those involved in converting food into usable energy. They also aid the body in managing oxidative stress and inflammation, which are critical factors in cardiovascular, kidney, and metabolic health issues. Vitamin B2 has been identified as influencing plasma total homocysteine levels, while vitamin B6 participates in homocysteine metabolism pathways.
It is important to note that the study was cross-sectional, meaning it measured diet and health at a single point in time, thus it cannot establish a cause-and-effect relationship. The researchers acknowledged that individuals with more advanced disease may alter their eating habits due to changes in appetite, illness, or dietary restrictions. Additionally, the study only accounted for B vitamins obtained from food sources, potentially underestimating total intake by excluding supplements.
The researchers emphasized the importance of obtaining sufficient B vitamins from food, although the findings do not definitively prove that B2 and B6 consumption protects against disease. Vitamin B2 is found in dairy, eggs, meat, and certain leafy greens, while vitamin B6 is present in poultry, fish, potatoes, chickpeas, and other foods. Whole-grain products, which are rich in B vitamins and have low glycemic indices, have been reported to help control glucose tolerance and mitigate insulin-related issues. The report concludes that a balanced, nutrient-rich diet is fundamental, and B2 and B6 should not be viewed in isolation from other nutrients.




